Breaking

Biosensor Development Company Grapheal Raises $3 Million

216views 0

Share it!

BREAKING

Biosensor Development Company Grapheal Raises $3 Million

216views 0

Share it!

Grapheal, a French developer of graphene-enhanced biosensors, has recently raised the equivalent of $3 Million usd to go towards their new Covid-19 testing technology and wound surveillance system.

Most notably, the funds are slated to go towards TestNPass, their rapid Covid-19 test which can detect the virus in 5 minutes or less. Their second technology that will benefit from this raising is the WoundLAB, a graphene-based patch that can record and store critical information about long-term wounds on the human body. The information can be collected with a smartphone, which makes this accessible and easy.

Dr. Vincent Bouchiat, CEO of Grapheal stated that the medical applications of graphene are yet to be fully realized, and with this round of funding their first product will reach the market within the year, helped greatly by the funding.

Source

Photo by Drew Hays on Unsplash

Alvin Leslie

Graphmatech Reveals Potential Copper Additive Breakthrough

Graphene-enhanced Face Masks Meet European Protection Standards

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>